- Home
- IOBT vs AXR Comparison
IOBT vs AXR Comparison
Compare IOBT & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- AXR
- Stock Information
- Founded
- IOBT 2014
- AXR 1961
- Country
- IOBT Denmark
- AXR United States
- Employees
- IOBT N/A
- AXR N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- AXR Homebuilding
- Sector
- IOBT Health Care
- AXR Real Estate
- Exchange
- IOBT Nasdaq
- AXR Nasdaq
- Market Cap
- IOBT 114.6M
- AXR 117.0M
- IPO Year
- IOBT 2021
- AXR N/A
- Fundamental
- Price
- IOBT $1.95
- AXR $21.10
- Analyst Decision
- IOBT Strong Buy
- AXR
- Analyst Count
- IOBT 3
- AXR 0
- Target Price
- IOBT $8.67
- AXR N/A
- AVG Volume (30 Days)
- IOBT 8.9M
- AXR 8.1K
- Earning Date
- IOBT 08-14-2025
- AXR 09-12-2025
- Dividend Yield
- IOBT N/A
- AXR N/A
- EPS Growth
- IOBT N/A
- AXR 89.60
- EPS
- IOBT N/A
- AXR 2.37
- Revenue
- IOBT N/A
- AXR $49,694,000.00
- Revenue This Year
- IOBT N/A
- AXR $12.31
- Revenue Next Year
- IOBT N/A
- AXR $8.40
- P/E Ratio
- IOBT N/A
- AXR $8.89
- Revenue Growth
- IOBT N/A
- AXR N/A
- 52 Week Low
- IOBT $0.66
- AXR $17.60
- 52 Week High
- IOBT $2.79
- AXR $39.68
- Technical
- Relative Strength Index (RSI)
- IOBT 56.62
- AXR 42.66
- Support Level
- IOBT $1.53
- AXR $19.94
- Resistance Level
- IOBT $1.77
- AXR $22.98
- Average True Range (ATR)
- IOBT 0.21
- AXR 0.98
- MACD
- IOBT 0.01
- AXR -0.14
- Stochastic Oscillator
- IOBT 33.33
- AXR 38.16
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.